Seegene Inc Asset Resilience Ratio

Latest as of June 2026: 24.96%

Seegene Inc asset resilience ratio. Seegene Inc (096530) has an Asset Resilience Ratio of 24.96% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 096530 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩316.04 Billion

≈ $214.18 Million USD Cash + Short-term Investments

Total Assets

₩1.27 Trillion

≈ $858.01 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Seegene Inc (2012–2025)

Asset resilience ratio of Seegene Inc from 2012 to 2025. This chart shows how Seegene Inc's Asset Resilience Ratio has changed over time. Read 096530 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Seegene Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Seegene Inc asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩316.04 Billion	24.96%
Total Liquid Assets	₩316.04 Billion	24.96%

Asset Resilience Insights

Good Liquidity Position: Seegene Inc maintains a healthy 24.96% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Seegene Inc Industry Peers by Asset Resilience Ratio

Compare Seegene Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Seegene Inc Asset Resilience Ratio by Year (2012–2025)

Seegene Inc asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Seegene Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	29.16%	₩360.33 Billion ≈ $244.19 Million	₩1.24 Trillion ≈ $837.48 Million	+7.34pp
2024-12-31	21.81%	₩262.92 Billion ≈ $178.17 Million	₩1.21 Trillion ≈ $816.80 Million	-4.60pp
2023-12-31	26.41%	₩330.50 Billion ≈ $223.98 Million	₩1.25 Trillion ≈ $848.09 Million	-17.00pp
2022-12-31	43.41%	₩603.78 Billion ≈ $409.17 Million	₩1.39 Trillion ≈ $942.51 Million	+11.63pp
2021-12-31	31.78%	₩473.45 Billion ≈ $320.85 Million	₩1.49 Trillion ≈ $1.01 Billion	+2.43pp
2020-12-31	29.35%	₩321.26 Billion ≈ $217.71 Million	₩1.09 Trillion ≈ $741.78 Million	+1.75pp
2019-12-31	27.60%	₩54.01 Billion ≈ $36.60 Million	₩195.72 Billion ≈ $132.63 Million	+4.73pp
2018-12-31	22.87%	₩37.46 Billion ≈ $25.39 Million	₩163.81 Billion ≈ $111.01 Million	+0.02pp
2017-12-31	22.85%	₩37.66 Billion ≈ $25.52 Million	₩164.84 Billion ≈ $111.71 Million	-12.70pp
2016-12-31	35.55%	₩73.80 Billion ≈ $50.01 Million	₩207.62 Billion ≈ $140.70 Million	+22.05pp
2015-12-31	13.50%	₩26.19 Billion ≈ $17.75 Million	₩194.05 Billion ≈ $131.50 Million	+5.12pp
2014-12-31	8.38%	₩11.60 Billion ≈ $7.86 Million	₩138.45 Billion ≈ $93.83 Million	+1.40pp
2013-12-31	6.97%	₩9.00 Billion ≈ $6.10 Million	₩129.04 Billion ≈ $87.45 Million	-2.75pp
2012-12-31	9.73%	₩8.13 Billion ≈ $5.51 Million	₩83.62 Billion ≈ $56.67 Million	--

pp = percentage points

About Seegene Inc

KQ:096530 Korea Biotechnology

Market Cap

$966.49 Million

₩1.43 Trillion KRW

Market Cap Rank

#8716 Global

#223 in Korea

Share Price

₩31300.00

Change (1 day)

-3.84%

52-Week Range

₩21850.00 - ₩38900.00

All Time High

₩140042.88